Weighted Average Number of Shares Outstanding, Diluted of PURE BIOSCIENCE, INC. from 30 Apr 2015 to 31 Jan 2026

Taxonomy & unit: us-gaap: shares
Description: The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary: PURE BIOSCIENCE, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Apr 2015 to 31 Jan 2026.
PURE BIOSCIENCE, INC. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Jan 2026 was 111,886,473, a 0.03% increase year-over-year.
PURE BIOSCIENCE, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 111,862,884, a 0.01% increase from 2024.
PURE BIOSCIENCE, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 111,856,473, a 0.41% increase from 2023.
PURE BIOSCIENCE, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 111,404,418, a 25% increase from 2022.
Source SEC data: View on sec.gov

Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)

Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)

Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)

Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

PURE BIOSCIENCE, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	111,886,473	+30,000	+0.03%	01 Nov 2025	31 Jan 2026	10-Q	17 Mar 2026	2026	Q2
Q3 2025	111,886,473	+30,000	+0.03%	01 Aug 2025	31 Oct 2025	10-Q	15 Dec 2025	2026	Q1
Q2 2025	111,862,884	+6,411	+0.01%	01 May 2025	31 Jul 2025	10-K	29 Oct 2025	2025	FY
Q1 2025	111,856,473	0	0%	01 Feb 2025	30 Apr 2025	10-Q	16 Jun 2025	2025	Q3
Q4 2024	111,856,473	0	0%	01 Nov 2024	31 Jan 2025	10-Q	17 Mar 2026	2026	Q2
Q3 2024	111,856,473	0	0%	01 Aug 2024	31 Oct 2024	10-Q	15 Dec 2025	2026	Q1
Q2 2024	111,856,473	+452,055	+0.41%	01 May 2024	31 Jul 2024	10-K	29 Oct 2025	2025	FY
Q1 2024	111,856,473	+500,000	+0.45%	01 Feb 2024	30 Apr 2024	10-Q	16 Jun 2025	2025	Q3
Q4 2023	111,856,473	+500,000	+0.45%	01 Nov 2023	31 Jan 2024	10-Q	17 Mar 2025	2025	Q2
Q3 2023	111,856,473	+500,000	+0.45%	01 Aug 2023	31 Oct 2023	10-Q	16 Dec 2024	2025	Q1
Q2 2023	111,404,418			01 May 2023	31 Jul 2023	10-K	29 Oct 2024	2024	FY
Q1 2023	111,356,473			01 Feb 2023	30 Apr 2023	10-Q	14 Jun 2024	2024	Q3
Q4 2022	111,356,473			01 Nov 2022	31 Jan 2023	10-Q	18 Mar 2024	2024	Q2
Q3 2022	111,356,473			01 Aug 2022	31 Oct 2022	10-Q	14 Dec 2023	2024	Q1
Q1 2021	87,223,141	+1,520,491	+1.8%	01 Feb 2021	30 Apr 2021	10-Q	15 Jun 2021	2021	Q3
Q1 2020	85,702,650	+9,101,638	+12%	01 Feb 2020	30 Apr 2020	10-Q	15 Jun 2021	2021	Q3
Q1 2019	76,601,012			01 Feb 2019	30 Apr 2019	10-Q	11 Jun 2020	2020	Q3
Q1 2017	62,679,644	-8,629,127	-12%	01 Feb 2017	30 Apr 2017	10-Q	08 Jun 2017	2017	Q3
Q1 2016	71,308,771	+30,472,146	+75%	01 Feb 2016	30 Apr 2016	10-Q	08 Jun 2017	2017	Q3
Q1 2015	40,836,625			01 Feb 2015	30 Apr 2015	10-Q	09 Jun 2016	2016	Q3

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	111,862,884	+6,411	+0.01%	01 Aug 2024	31 Jul 2025	10-K	29 Oct 2025	2025	FY
2024	111,856,473	+452,055	+0.41%	01 Aug 2023	31 Jul 2024	10-K	29 Oct 2025	2025	FY
2023	111,404,418	+22,568,994	+25%	01 Aug 2022	31 Jul 2023	10-K	29 Oct 2024	2024	FY
2022	88,835,424	+1,661,112	+1.9%	01 Aug 2021	31 Jul 2022	10-K	30 Oct 2023	2023	FY
2021	87,174,312	+2,562,490	+3%	01 Aug 2020	31 Jul 2021	10-K	28 Oct 2021	2021	FY
2020	84,611,822	+11,731,338	+16%	01 Aug 2019	31 Jul 2020	10-K	28 Oct 2021	2021	FY
2019	72,880,484			01 Aug 2018	31 Jul 2019	10-K	08 Oct 2020	2020	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.